Skip to main content
Log in

Introduction

  • Article
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Acknowledgements

PAREXEL MMS provided writing assistance, comprising preparation of a draft from slides and audio transcript, preparation of figures and obtaining copyright permissions, proofreading, and reference checking.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eberhard Ritz.

Ethics declarations

Competing interests

E Ritz has received speaker's honoraria from Abbott, Amgen, Boehringer Ingleheim, Novartis and Roche. B Dahlöf has acted as a consultant for Boehringer Ingleheim, Merck, Novartis and Pfizer; he has also received speaker's honoraria from Boehringer Ingleheim, Merck, Novartis, Pfizer and Servier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritz, E., Dahlöf, B. Introduction. Nat Rev Cardiol 5 (Suppl 1), S1–S2 (2008). https://doi.org/10.1038/ncpcardio0807

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0807

  • Springer Nature Limited

Navigation